Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in European Urology Open Science
- Vol. 30, 1-10
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (TL1TR001443)
This publication has 20 references indexed in Scilit:
- Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicJournal of Clinical Oncology, 2017
- Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceEuropean Urology, 2017
- Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic ReviewEuropean Urology, 2014
- Muscle‐invasive bladder cancer: evaluating treatment and survival in the N ational C ancer D ata B aseBJU International, 2014
- Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data BaseEuropean Urology, 2013
- ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the BladderEuropean Urology, 2013
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder CancerNew England Journal of Medicine, 2012
- Compliance with guidelines for patients with bladder cancerCancer, 2011
- Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center ExperienceEuropean Urology, 2009
- Cystectomy for Transitional Cell Carcinoma of the Bladder: Results of a Surgery Only Series in the Neobladder EraJournal of Urology, 2006